SCOPUS 정보 검색 플랫폼

PharmacoEconomics

Volumn 18, Issue SUPPL. 1, 2000, Pages 21-32

The distribution of sales revenues from pharmaceutical innovation

(2) Grabowski, H G a Vernon, J a

a DUKE UNIVERSITY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; AZITHROMYCIN; CLARITHROMYCIN; FLUOXETINE; NEW DRUG; OMEPRAZOLE; ORPHAN DRUG; PACLITAXEL; PRAVASTATIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SERTRALINE; SIMVASTATIN;

CONFERENCE PAPER; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; INVESTMENT; MANAGED CARE; PATENT; PRIORITY JOURNAL; PROFIT; UNITED STATES;

EID: 0033763969 PISSN: 11707690 EISSN: None Source Type: Journal
DOI: 10.2165/00019053-200018001-00005 Document Type: Conference Paper

Times cited : (47)

References (21)

1
- 0028558896
- Returns to RandD on new drug introductions in the 1980s
- (1994) J Health Econ , vol.13 , pp. 383-406
- Grabowski, H.¹ Vernon, J.²

2
- 0001647605
- A new look at the returns and risks to pharmaceutical RandD
- (1990) Manage Sci , vol.36 , Issue.7 , pp. 167-185
- Grabowski, H.¹ Vernon, J.²

3
- 0034423944
- Uncertainty and the size distribution of rewards from technological innovation
- (2000) J Evolut Econ , vol.10 , pp. 175-200
- Scherer, F.M.¹ Harkoff, D.² Kudies, J.³

4
- 0003514645
- New perspectives on economic growth and technological innovation
- Ch. 5. Washington DC: Brookings Institution Press
- (1999) , pp. 53-88
- Scherer, F.M.¹

5
- 0034406123
- The determinants of pharmaceutical research and development expenditures
- (2000) J Evolut Econ , vol.10 , pp. 201-215
- Grabowski, H.¹ Vernon, J.²

6
- 0003566752
- Washington, DC: Federal Trade Commission Staff Report, Government Printing Office, Feb
- (1977) Sales, promotion and product differentiation in two prescription drug markets
- Bond, R.¹ Lean, D.²

7
- 0000308424
- The roles of marketing, product quality and price competition in the growth and composition of the US anti ulcer drug industry
- Bresnahan T, Gordon RJ, editors. The economics of new goods. Chicago: University of Chicago Press
- (1997) , pp. 277-328
- Berndt, E.¹ Bui, L.² Lucking-Reily, D.³

8
- 0025868362
- The cost of innovation in the pharmaceutical industry
- (1991) J Health Econ , vol.10 , pp. 107-142
- DiMasi, J.¹ Hansen, R.² Grabowski, H.³

9
- 0030745126
- Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions
- (1997) Soc Sci Med , vol.45 , Issue.4 , pp. 535-554
- Grabowski, H.¹ Mullins, C.D.²

10
- 0004304416
- New York: Haworth Press
- PBMs: Reshaping the pharmaceutical distribution network , pp. 1998
- Shulman, S.¹ Healy, E.M.² Lasagna, L.³

11
- 0026439799
- Implementation of the orphan act: 1983-91
- (1992) Food Law J , vol.47 , Issue.4 , pp. 363-404
- Schulman, S.¹ Bienz-Tadmor, B.² Seo, P.S.³

12
- 0029838687
- Vernon 3 Longer patents for increased generic competition in the US the Waxman-Hatch Act after one decade
- (1996) Pharmacoeconomics , vol.10 , Issue.SUPPL. 2 , pp. 110-123
- Grabowski, H.¹

13
- 0033873835
- Effective patent life in pharmaceuticals
- (2000) Int J Technol Manag , vol.19 , pp. 98-120
- Grabowski, H.¹ Vernon, J.²

14
- 0010259325
- Innovation and structural change in pharmaceuticals and biotechnology
- (1994) Indust Corp Changes , vol.3 , Issue.2 , pp. 435-449
- Grabowski, H.¹ Vernon, J.²

16
- 0001103968
- Industrial policy and international competitiveness in the pharmaceutical industry
- Helms R, editor. Competitive strategies in the pharmaceutical industry, Washington DC: AEI Press
- (1996) , pp. 107-129
- Thomas III, L.G.¹

17
- 0000887602
- The structure and governance of venture capital organizations
- (1990) J Financ Econ , vol.27 , pp. 473-521
- Sahlman, W.¹

18
- 0004065005
- Biotechnology and the economics of discovery in the pharmaceutical industry
- Ch. 3. London: Office of Health Economics
- Simpson, H.¹

19
- 0029128834
- Success rates for new drugs entering clinical testing in the United States
- (1995) Clin Pharmacol Ther , vol.58 , Issue.1 , pp. 1-14
- DiMasi, J.A.¹

20
- 0030909882
- The effect of pharmacoeconomics on company research and development decisions
- May
- (1997) Pharmacoeconomics , vol.11 , Issue.5 , pp. 389-397
- Grabowski, H.¹

21
- 0001962165
- Prospects for returns to pharmaceutical RandD under health care reform
- Helms R, editor. Competitive strategies in the pharmaceutical industry, Washington DC: AEI Press
- (1996) , pp. 194-207
- Grabowski, H.¹ Vernon, J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.